Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly

被引：0
|
作者：
Ignacio Bernabéu
Carmen Fajardo
Mónica Marazuela
Fernando Cordido
Eva María Venegas
Pedro de Pablos-Velasco
Gonzalo Piedrola Maroto
María Pilar Olvera
Isabel Pavón de Paz
Davide Carvalho
Carme Romero
Guillermo De la Cruz
Cristina Álvarez Escolá
机构：
[1] Hospital Clínico Universitario Santiago de Compostela,Endocrinology and Nutrition Department
[2] Hospital Universitario de La Ribera,Endocrinology and Nutrition Department
[3] Hospital Universitario La Princesa,Endocrinology and Nutrition Department
[4] Universidad Autónoma Madrid,Faculty of Health Sciences and INIBIC, University of A Coruña, and Endocrinology and Nutrition Department
[5] Instituto Princesa,Endocrinology and Nutrition Department
[6] Complejo Hospitalario Universitario de A Coruña,Endocrinology and Nutrition Department
[7] Hospital Universitario Virgen del Rocío,Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário São João
[8] University of Las Palmas de Gran Canaria. Spain,Endocrinology and Nutrition Department
[9] Endocrinology and Nutrition Departament Hospital Universitario Virgen de las Nieves,undefined
[10] Endocrinology and Nutrition Departament,undefined
[11] Hospital Universitario Nuestra Señora de Candelaria,undefined
[12] Endocrinology and Nutrition Departament,undefined
[13] Hospital Universitario de Getafe,undefined
[14] Faculty of Medicine,undefined
[15] i3S,undefined
[16] Universidade do Porto,undefined
[17] Adknoma Health Research S.L.,undefined
[18] Ipsen Pharma,undefined
[19] Hospital Universitario La Paz,undefined
来源：
Endocrine | 2020年 / 70卷
关键词：
Acromegaly; Lanreotide; Insulin-like growth factor 1; Somatostatin; Growth hormone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：575 / 583
页数：8
相关论文
共 50 条
  • [1] Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly
    Bernabeu, Ignacio
    Fajardo, Carmen
    Marazuela, Monica
    Cordido, Fernando
    Maria Venegas, Eva
    de Pablos-Velasco, Pedro
    Piedrola Maroto, Gonzalo
    Pilar Olvera, Maria
    Pavon de Paz, Isabel
    Carvalho, Davide
    Romero, Carme
    De la Cruz, Guillermo
    Alvarez Escola, Cristina
    ENDOCRINE, 2020, 70 (03) : 575 - 583
  • [2] Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study
    Neggers, Sebastian J. C. M. M.
    Pronin, Vyacheslav
    Balcere, Inga
    Lee, Moon-Kyu
    Rozhinskaya, Liudmila
    Bronstein, Marcello D.
    Gadelha, Monica R.
    Maisonobe, Pascal
    Sert, Caroline
    van der Lely, Aart Jan
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (03) : 313 - 323
  • [3] BUDGET IMPACT ANALYSIS OF LANREOTIDE AUTOGEL 120 MG IN THE TREATMENT OF ACROMEGALY IN POLAND
    Orlewska, E.
    Kos-Kudla, B.
    Sowinski, J.
    Sworczak, K.
    Zgliczynski, W.
    VALUE IN HEALTH, 2016, 19 (07) : A668 - A668
  • [4] Efficacy and Acceptability of Lanreotide Autogel® 120 mg at Different Dose Intervals in Patients with Acromegaly Previously Treated with Octreotide LAR
    Schopohl, J.
    Strasburger, C. J.
    Caird, D.
    Badenhoop, K.
    Beuschlein, F.
    Droste, M.
    Ploeckinger, U.
    Petersenn, S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (03) : 156 - 162
  • [5] Extended Dosing Intervals (EDIs) with Lanreotide Autogel/Depot 120 Mg Can be Effective in Acromegalic Patients Biochemically Controlled with Octreotide LAR 10 or 20 Mg: The Lead Study
    van der Lely, Aart-Jan
    Pronin, Vyacheslav
    Balcere, Inga
    Lee, Moon-Kyu
    Rozhinskaya, Liudmila
    Bronstein, Marcello D.
    Gadelha, MA'nica
    Maisonobe, Pascal
    Sert, Caroline
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [6] Spotlight on Lanreotide Autogel® in Acromegaly
    Jamie D. Croxtall
    Lesley J. Scott
    BioDrugs, 2008, 22 : 275 - 277
  • [7] Lanreotide Autogel® in the Management of Acromegaly
    Mark E. Molitch
    Drugs, 2008, 68 : 724 - 724
  • [8] Spotlight on lanreotide Autogel® in acromegaly
    Croxtall, Jamie D.
    Scott, Lesley J.
    BIODRUGS, 2008, 22 (04) : 275 - 277
  • [9] Lanreotide autogel in acromegaly - a decade on
    Kyriakakis, Nikolaos
    Chau, Vincent
    Lynch, Julie
    Orme, Steve M.
    Murray, Robert D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (18) : 2681 - 2692
  • [10] Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
    Caron, Philippe J.
    Bevan, John S.
    Petersenn, Stephan
    Flanagan, Daniel
    Tabarin, Antoine
    Prevost, Gaetan
    Maisonobe, Pascal
    Clermont, Antoine
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (04): : 1282 - 1290
12345